A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
Clinical trial NCT06898450 · RECRUITING
Trial details
- NCT number
- NCT06898450
- Sponsor
- Nimbus Wadjet, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-31
- Primary completion
- 2031-10-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.